You're reading a SIGNA Wire case file. Get alerts like this for free. Sign in · Learn more →
UCB Biosciences Inc.FDAMed source confidence · 80%Jun 22, 2026, 10:00 AM UTC · 16d ago
UCB Biosciences Inc. — FDA Class II (D-0546-2026)
Case File
UCB Biosciences Inc is recalling 141,708 cartons of a human prescription drug due to lack of assurance of sterility. This recall is classified as a safety issue. The affected products are identified by NDC numbers 50474-700, 50474-710, and 50474-750.
•UCB Biosciences Inc is recalling 141,708 cartons of a human prescription drug.
•The recall is due to lack of assurance of sterility.
•Affected products include NDC numbers 50474-700, 50474-710, and 50474-750.
•Patients should check their medicine cabinets for these products.
Why This Matters
Patients using the recalled products may be at risk due to sterility issues. They should stop using the affected drugs and consult their healthcare provider.